Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening

Gastroenterology

Volumn 141, Issue 3, 2011, Pages

  Aikou, Susumu ^a   Ohmoto, Yasukazu ^b   Gunji, Toshiaki ^c   Matsuhashi, Nobuyuki ^c   Ohtsu, Hiroshi ^a   Miura, Hirona ^a   Kubota, Kensuke ^d   Yamagata, Yukinori ^a   Seto, Yasuyuki ^a   Nakajima, Atsushi ^d   Goldenring, James R ^e   Kaminishi, Michio ^f   Nomura, Sachiyo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c Kanto Teishin Hospital   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Showa General Hospital   (Japan)

Author keywords

Blood Test; Diagnostic; H pylori; Prevention; Stomach Cancer

Indexed keywords

GROWTH FACTOR; IMMUNOGLOBULIN G ANTIBODY; PEPSINOGEN I; PEPSINOGEN II; TREFOIL FACTOR FAMILY 1; TREFOIL FACTOR FAMILY 2; TREFOIL FACTOR FAMILY 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER SCREENING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERPLASIA; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; METAPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SEX RATIO; STOMACH CANCER;

EID: 80052107345     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.05.040     Document Type: Article

References (45)

1. P. Pisani, D.M. Parkin, and F. Bray Estimates of the worldwide mortality from 25 cancers in 1990 Int J Cancer 83 1999 18 29 (Pubitemid 29409471)
2. C. Hamashima, D. Shibuya, and H. Yamazaki The Japanese guidelines for gastric cancer screening Jpn J Clin Oncol 38 2008 259 267 (Pubitemid 351583989)
3. K. Miki, M. Ichinose, and N. Kakei The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer Adv Exp Med Biol 362 1995 139 143
4. A.G. Plaut Trefoil peptides in the defense of the gastrointestinal tract N Engl J Med 336 1997 506 507 (Pubitemid 27074365)
5. S. Ribieras, C. Tomasetto, and M.C. Rio The pS2/TFF1 trefoil factor, from basic research to clinical applications Biochim Biophys Acta 1378 1998 F61 F77
6. S. Kjellev The trefoil factor familysmall peptides with multiple functionalities Cell Mol Life Sci 66 2009 1350 1369
7. W.M. Wong, R. Poulsom, and N.A. Wright Trefoil peptides Gut 44 1999 890 895 (Pubitemid 29244230)
8. M. Blaser, and J. Parsonnet Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia J Clin Invest 94 1994 4 8
9. H.M.T. El-Zimaity, H. Ota, and D.Y. Graham Patterns of gastric atrophy in intestinal type gastric carcinoma Cancer 94 2002 1428 1436 (Pubitemid 34212636)
10. P. Correa A human model of gastric carcinogenesis Cancer Res 48 1988 3554 3560
11. M.I. Filipe, N. Munoz, and I. Matko Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia Int J Cancer 57 1994 324 329 (Pubitemid 24168604)
12. T. Hattori Development of adenocarcinoma in the stomach Cancer 57 1986 1528 1534
13. T. Takizawa, and M. Koike Minute gastric carcinoma from pathomorphological aspect-reconsideration concerning histogenesis of gastric carcinomas Stomach Intestine 23 1998 791 800
14. T. Hattori, and S. Fujita Tritiated thymidine autoradiographic study on histogenesis and spreading of intestinal metaplasia in human stomach Pathol Res Pract 164 1979 224 237 (Pubitemid 9210872)
15. T. Hattori, B. Helpap, and P. Gedigk The morphology and cell kinetics of pseudopyloric glands Virchows Arch B Cell Pathol Oncl Mol Pathol 39 1982 31 40 (Pubitemid 12133306)
16. H.H. Xia, J.S. Kalantar, and N.J. Talley Antral-type mucosa in the gastric incisura, body and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia Am J Gastroenterol 95 2000 114 121 (Pubitemid 30041544)
17. P.H. Schimidt, J.R. Lee, and V. Joshi Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma Lab Invest 79 1999 639 646 (Pubitemid 29283417)
18. H. Yamaguchi, J.R. Goldenring, and M. Kaminishi Association of spasmolytic polypeptide expressing metaplasia (SPEM) with carcinogen administration and oxyntic atrophy in rats Lab Invest 82 2002 1045 1052
19. A.M. Halldorsdottir, M. Sigurdardottir, and J.G. Jonasson Spasmolytic polypeptide expressing metaplasia (SPEM) associated with gastric cancer in Iceland Dig Dis Sci 48 2003 431 441 (Pubitemid 36324148)
20. N. Yoshizawa, Y. Takenaka, and H. Yamaguchi Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori Lab Invest 87 2007 1265 1276 (Pubitemid 350126706)
21. J.C. Machado, F. Carneiro, and N. Blin Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosa Eur J Cancer Prev 5 1996 169 179 (Pubitemid 26228433)
22. Y. Luqmani, C. Bennett, and I. Paterson Expression of the pS2 gene in normal, benign and neoplastic human stomach Int J Cancer 44 1989 806 812 (Pubitemid 20007976)
23. W. Muller, and F. Borchard pS2 protein in gastric carcinoma and normal gastric mucosa: association with clinicopathological parameters and patient survival J Pathol 171 1993 263 269 (Pubitemid 24022987)
24. J.C. Machado, F. Carneiro, and P. Ribeiro pS2 protein expression in gastric carcinoma An immunohistochemical and immunoradiometric study Eur J Cancer 32A 1996 1585 1590 (Pubitemid 26279128)
25. B. Theisinger, C. Welter, and G. Seitz Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma Eur J Cancer 27 1991 770 773
26. S.Q. Shi, J.T. Cai, and J.M. Yang Expression of trefoil factors 1 and 2 in precancerous condition and gastric cancer World J Gastroenterol 12 2006 3119 3122
27. J.C. Machado, A.M. Nogueira, and F. Carneiro Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6) J Pathol 190 2000 437 443 (Pubitemid 30163583)
28. D. Taupin, J. Pedersen, and M. Familari Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium Lab Invest 81 2001 397 408 (Pubitemid 32245071)
29. A.M. Hanby, R. Poulsom, and S. Singh Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach Gastroenterology 105 1993 1110 1116 (Pubitemid 23281500)
30. M. Dinis-Ribeiro, G. Yamaki, and K. Miki Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening J Med Screen 11 2004 141 147 (Pubitemid 39274096)
31. H. Ohata, M. Ichinose, and K. Miki Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography Cancer Sci 96 2005 713 720 (Pubitemid 41723549)
32. E.M. Vestergaard, J. Brynskov, and K. Ejskjaer Immunoassays of human trefoil factors 1 and 2: measured on serum from patients with inflammatory bowel disease Scand J Clin Lab Invest 64 2004 146 156 (Pubitemid 38491386)
33. K. Miki, M. Ichinose, and N. Kakei The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer Adv Exp Med Biol 362 1995 139 143
34. C. Hamashima, D. Shibuya, and H. Yamazaki The Japanese guidelines for gastric cancer screening Jpn J Clin Oncol 38 2008 259 267 (Pubitemid 351583989)
35. M. Dinis-Ribeiro, G. Yamaki, and K. Miki Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening J Med Screen 11 2004 141 147 (Pubitemid 39274096)
36. L. Zhang, W.J. Blot, and W.C. You Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population Cancer Epidemiol Biomarkers Prev 5 1996 627 630 (Pubitemid 26265157)
37. M. Camorlinga-Ponce, L. Flores-Luna, and E. Lazcano-Ponce Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies Cancer Epidemiol Biomarkers Prev 17 2008 2498 2504
38. M. Vauhkonen, H. Vauhkohnen, and P. Sipponen Pathology and molecular biology of gastric cancer Best Pract Res Clin Gastroenterol 20 2006 651 674 (Pubitemid 44418021)
39. M. Tatemichi, S. Sasazuki, and M. Inoue Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen Acta Oncol 47 2008 360 365 (Pubitemid 351414940)
40. H. Kirikoshi, and M. Katoh Expression of TFF1, TFF2 and TFF3 in gastric cancer Int J Oncol 21 2002 655 659
41. J.H. Kim, M.A. Kim, and H.S. Lee Comparative analysis of protein expressions in primary and metastatic gastric carcinomas Hum Pathol 40 2009 314 322
42. S. Suemori, K. Lynch-Devaney, and D.K. Podolsky Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family Proc Natl Acad Sci U S A 88 1991 11017 11021 (Pubitemid 21915970)
43. H. Gronbaek, E.M. Vestergaard, and H. Hey Serum trefoil factors in patients with inflammatory bowel disease Digestion 74 2006 33 39 (Pubitemid 44835689)
44. H. Mashimo, D.C. Wu, and D.K. Podolsky Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor Science 274 1996 262 265 (Pubitemid 26353206)
45. E.M. Vestergaard, M. Borre, and S.S. Poulsen Plasma levels of trefoil factors are increased in patients with advanced prostate cancer Clin Cancer Res 12 2006 807 812 (Pubitemid 43259861)